Calendar Aclaris Therapeutics, Inc.

Equities

ACRS

US00461U1051

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
1.26 USD +6.78% Intraday chart for Aclaris Therapeutics, Inc. +5.88% +20.00%

Chart calendar Aclaris Therapeutics, Inc.

0dd6a11eb29dad.Lb6uoLtUcU_1VOg2plftRv__pbaFH6v8Roo7MYnZ74Y.GInojd4xIzaYAr5T5QbcKKzN4v3WasOQIeB1fPvpm-9098XN-TkhGKNnhw~180e6436fd1939de9f005a91e49b0017

Upcoming events on Aclaris Therapeutics, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)

Past events on Aclaris Therapeutics, Inc.

2024-02-27 07:00 am Q4 2023 Earnings Release
2023-11-13 08:00 am Zunsemetinib Phase IIb Rheumatoid Arthritis Trial Results Call
2023-11-06 07:00 am Q3 2023 Earnings Release
2023-09-26 10:30 am Cantor Global Healthcare Conference
2023-08-07 07:00 am Q2 2023 Earnings Release
2023-06-14 07:40 pm Goldman Sachs Global Healthcare Conference
2023-06-08 04:30 pm Jefferies Global Healthcare Conference
2023-06-01 09:00 am Annual General Meeting
2023-05-08 08:00 am Q1 2023 Earnings Call
2023-05-08 07:00 am Q1 2023 Earnings Release
2023-03-30 01:00 pm H.C. Wainwright Autoimmune & Inflammatory Disease Conference
2023-02-23 07:00 am FY 2022 Earnings Release
2023-02-14 09:20 am SVB Securities Global Biopharma Conference
2023-01-11 05:15 pm JP Morgan Healthcare Conference
2022-11-29 09:30 am Piper Sandler Healthcare Conference
2022-11-16 12:00 pm Jefferies London Healthcare Conference
2022-11-08 07:00 am Q3 2022 Earnings Release
2022-09-12 07:00 am H.C. Wainwright Global Investment Conference
2022-08-03 07:00 am Interim 2022 Earnings Release
2022-06-08 11:30 am Jefferies Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,23
12,7
-66.79%
6,48
6,29
2.97%
6,76
7,05
-4.13%
29,8
24,0
24%
31,2
18,3
70.43%

7,78

EBITDA
Million USD
Released
Forecast
Spread
-86,1
-84,1
-2.37%
0,00
0,00
-
0,00
0,00
-
-89,1
-84,1
-5.84%
-96,5
-123
21.74%

-93,5

EBIT
Million USD
Released
Forecast
Spread
-92,6
-120
22.96%
-50,9
-48,4
-5.08%
-89,7
-90,1
0.38%
-89,9
-91,7
2.05%
-97,4
-119
17.94%

-61,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-114
-129
12.29%
-51,3
-48,6
-5.7%
-90,9
-91,1
0.21%
-86,9
-91,0
4.51%
-88,8
-113
21.66%

-76,1

Net income
Million USD
Released
Forecast
Spread
-161
-131
-23.07%
-51,0
-48,7
-4.83%
-90,9
-91,0
0.2%
-86,9
-90,5
3.94%
-88,5
-112
20.68%

-73,7

EPS
USD
Released
Forecast
Spread
-3,90
-3,17
-22.9%
-1,20
-1,15
-4.05%
-1,60
-1,61
0.42%
-1,33
-1,46
8.98%
-1,27
-1,60
20.68%

-0,98

Announcement Date25/02/2025/02/2124/02/2223/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
1,50
1,80
-16.56%
1,45
1,67
-12.74%
1,53
1,61
-5.2%
19,0
1,60
1085.34%
7,75
1,99
288.82%
2,53
1,75
44.6%
1,87
1,90
-1.6%
9,28
1,57
489.83%
17,6
5,05
247.87%

2,00


2,01


2,06


2,06


1,23

EBIT
Million USD
Released
Forecast
Spread
-22,9
-23,2
1.14%
-18,9
-24,6
23.11%
-21,0
-24,5
14.23%
-20,9
-26,5
21.34%
-29,1
-29,8
2.57%
-29,9
-29,1
-2.8%
-31,8
-31,8
-0.14%
-31,6
-34,3
7.92%
-4,05
-25,2
83.92%

-14,3


-14,2


-13,9


-14,5


-35,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-22,8
-23,2
1.58%
-18,8
-24,6
23.56%
-20,5
-24,4
15.97%
-20,0
-26,9
25.86%
-27,6
-30,8
10.22%
-28,2
-29,0
2.75%
-29,6
-32,1
7.92%
-29,3
-34,3
14.77%
-1,86
-25,2
92.62%

-20,4


-18,2


-17,1


-16,9


-34,9

Net income
Million USD
Released
Forecast
Spread
-22,8
-23,1
1.44%
-18,8
-24,8
24.29%
-20,5
-23,8
13.71%
-20,0
-26,3
24.16%
-27,6
-30,5
9.35%
-28,2
-29,2
3.62%
-29,6
-31,7
6.67%
-29,3
-33,9
13.81%
-1,49
-23,6
93.69%

-20,3


-18,0


-16,4


-16,0


-34,9

EPS
USD
Released
Forecast
Spread
-0,37
-0,37
-1.37%
-0,31
-0,40
23.14%
-0,31
-0,36
13.49%
-0,30
-0,40
24.19%
-0,41
-0,46
10.14%
-0,42
-0,44
4.55%
-0,42
-0,45
7.44%
-0,41
-0,48
14.81%
-0,02
-0,33
94.01%

-0,27


-0,24


-0,21


-0,21


-0,24

Announcement Date24/02/2210/05/2203/08/2208/11/2223/02/2308/05/2307/08/2306/11/2327/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise